lrrk2 g2019s mutation attenuates microglial motility by inhibiting focal adhesion kinase
Published 8 years ago • 494 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
0:25
measuring protein interactions with lrrk2
-
0:25
microimaging
-
1:02:26
keynote presentation: interplay between lrrk2 protein kinase and rab gtpases in parkinson's disease
-
1:31
identifying a new link between trem2 and il-4 signaling in microglia
-
2:28
tolebrutinib reduces new mri lesions in highly active relapsing ms
-
2:25
preclinical to clinical mri
-
2:06
second-line myelofibrosis treatment – the potential of jak2 inhibitor ns-018
-
19:53
session 1, presentation 2 gulick, roy
-
3:05
patient journey smile – jetarian, songur, fleischmann
-
1:42
▶ ask the md what is lrrk2
-
31:14
update on jak2 inhibitors by srdan verstovsek, md
-
5:46
dr nic dzamko on parkinson's disease
-
22:42
the inhibitory role of specific macrophages in rcc
-
4:43
characterizing antibody s16007d for p2ry12 detection in microglia
-
1:21:25
dario alessi, ph.d. - "understanding the lrrk2 kinase and its role in parkinson’s disease"
-
1:11
neuroradiology case 52
-
1:51
neuroradiology case 48
-
1:51
lrrk2: a pivotal regulator of neutrophil migration to infection sites
-
5:28
efficacy and immune correlates of the sra737 plus ldg regimen in combination with anti-pd-l1 in ...